TABLE 6.
Comparison of reports on MICs for B. anthracis
Antibiotic | Source or reference | Test method | No. of strains | MIC (μg/ml)
|
Breakpointsa
|
Interpretation (%)b
|
|||||
---|---|---|---|---|---|---|---|---|---|---|---|
Range | 50% | 90% | S (≤) | R (≥) | Se | I | R | ||||
Amoxycillin-clavulanic | This study | Etest | 45 | 0.016-0.5 | 0.032 | 0.047 | 4 | 8 | 100 | ||
acid | This study | Agar dilution | 10 | 0.015-0.06 | 0.03 | 0.06 | 100 | ||||
4 | Agar dilution | 96 | 0.125-16 | 0.125 | 4 | 88.5 | 11.5 | ||||
10 | Agar dilution | 22 | 0.015-0.015 | 0.015 | 0.015 | 100 | |||||
22 | Agar dilution | 70 | 0.03-64 | 0.125 | 0.06 | 99 | 1 | ||||
Azithromycin | This study | Etest | 73 | 1-12 | 3 | 6 | 2 | 8 | 26 | 64 | 10 |
Cefotaxime | This study | Etest | 76 | 3->32 | >32 | >32 | 8 | 64 | 1 | 99c | |
This study | Agar dilution | 10 | 16-64 | 32 | 32 | 100 | |||||
10 | Disk diffusion | 22 | 4 | 14 | 82 | ||||||
10 | Agar dilution | 22 | 8-32 | 32 | 32 | ||||||
29 | Disk diffusion | 44 | 100 | ||||||||
Ciprofloxacin | This study | Etest | 76 | 0.032-0.094 | 0.064 | 0.094 | ≤0.5 | 100 | |||
This study | Agar dilution | 10 | 0.06 | 0.06 | 0.06 | 100 | |||||
4 | Agar dilution | 96 | 0.03-0.5 | 0.06 | 0.25 | 100 | |||||
9 | Etest | 25 | 0.032-0.38 | 0.094 | 0.094 | 100 | |||||
10 | Agar dilution | 22 | 0.03-0.06 | 0.03 | 0.06 | 100 | |||||
10 | Disk diffusion | 22 | 100 | ||||||||
12 | Agar dilution | 40 | <0.008-0.12 | 0.03 | 0.06 | 100 | |||||
Klugman et al.f | NCCLS methods | 25 | 0.0625-0.125 | 0.0625 | 0.0625 | 100 | |||||
22 | Agar dilution | 70 | 0.03-0.06 | 0.06 | 0.06 | 100 | |||||
26 | Agar dilution | 65 | 0.03-0.12 | 0.06 | 0.06 | 100 | |||||
Brooks et al.d | Microdilution | 12 | <0.25 | <0.25 | <0.25 | 100 | |||||
Erythromycin | This study | Etest | 69 | 0.5-4 | 1 | 1.5 | 0.5 | 8 | 15 | 85 | |
This study | Agar dilution | 10 | 0.5-2 | 1 | 2 | 10 | 90 | ||||
4 | Agar dilution | 96 | 0.5-4 | 1 | 1 | 95.4 | 4.6 | ||||
10 | Disk diffusion | 22 | 100 | ||||||||
Klugman et al. | NCCLS methods | 25 | 0.125-4 | 0.5 | 1 | NA | |||||
22 | Agar dilution | 70 | 0.25-1 | 0.5 | 1 | NA | NA | 0 | |||
26 | Agar dilution | 65 | 0.5-1 | 1 | 1 | 3 | 97 | ||||
29 | Disk diffusion | 44 | 100 | ||||||||
Brooks et al. | Microdilution | 12 | 0.25-4 | 0.5 | 1 | 8 | 92 | ||||
Gentamicin | This study | Etest | 75 | 0.064-0.5 | 0.25 | 0.38 | 4 | 16 | 100 | ||
This study | Agar dilution | 10 | 0.25-0.5 | 0.25 | 0.5 | 100 | |||||
4 | Agar dilution | 96 | 0.125-0.5 | 0.25 | 0.5 | 100 | |||||
10 | Agar dilution | 22 | 0.03-0.25 | 0.06 | 0.125 | 100 | |||||
10 | Disk diffusion | 22 | 100 | ||||||||
22 | Agar dilution | 70 | 0.06-0.5 | 0.125 | 0.25 | 100 | |||||
29 | Disk diffusion | 44 | 97.8 | 2.2 | |||||||
Penicillin | This study | Etest | 74 | <0.016->32 | <0.016 | 0.023 | 0.12 | 0.25 | 97 | 3 | |
This study | Agar dilution | 8 | 0.015-0.5 | 0.015 | 0.015 | —e | |||||
4 | Agar dilution | 96 | 0.125-16 | 0.125 | 8 | 88.5 | 11.5 | ||||
9 | Etest | 25 | <0.016-0.5 | 0.042 | 0.236 | 88 | 12 | ||||
10 | Agar dilution | 22 | 0.015-0.03 | 0.015 | 0.015 | 100 | |||||
10 | Disk diffusion | 22 | 100 | ||||||||
12 | Agar dilution | 40 | 0.016-0.03 | 0.016 | 0.016 | 100 | |||||
22 | Agar dilution | 70 | 0.015-64 | 0.06 | 0.125 | 99 | 1 | ||||
26 | Agar dilution | 65 | <0.06-128 | ≤0.06 | ≤0.06 | 97 | 3 | ||||
29 | Disk diffusion | 44 | 84.1 | 15.9 | |||||||
Tetracycline | This study | Etest | 71 | 0.016-0.094 | 0.023 | 0.032 | 1 | 100 | |||
This study | Agar dilution | 10 | 0.015-0.06 | 0.015 | 0.03 | 100 | |||||
10 | Disk diffusion | 22 | 100 | ||||||||
22 | Agar dilution | 70 | 0.6-1 | 0.125 | 0.125 | 100 | |||||
26 | Agar dilution | 65 | 0.03-0.06 | 0.03 | 0.06 | 100 | |||||
29 | Disk diffusion | 44 | 100 | ||||||||
Vancomycin | This study | Etest | 74 | 0.75-5 | 2 | 3 | 4 | 32 | 99 | 1 | |
This study | Agar dilution | 10 | 1-4 | 4 | 4 | 100 | |||||
4 | Agar dilution | 96 | 0.25-2 | 1 | 1 | 100 | |||||
10 | Agar dilution | 22 | 0.25-1 | 1 | 1 | 95 | 5 | ||||
10 | Disk diffusion | 22 | 95 | 5 | |||||||
26 | Agar dilution | 65 | 0.5-2 | 2 | 2 | 100 |
NCCLS MIC interpretive standards (see footnotes to Table 3). Interpretations in the cited reports predate the newly available NCCLS breakpoints for B. anthracis and ciprofloxacin, penicillin, and tetracycline.
S, susceptible; I, intermediate; R, resistant; NA, information not available.
Resistance inferred. The highest level on the strips used was 32 μg/ml.
T. Brooks, P. C. B. Turnbull, and A. Maule, unpublished results.
—, for penicillin, ASC 32, ASC 70, and ASC 183 resistant; remainder susceptible.
K.P. Klugman, J. Frean, L. Arntzen, V. Yeldandi, and S. Bukofzer, Addendum, Abstr. 41st Intersci. Conf. Antimicrob. Agents Chemother., abstr. UL-20, p. 7, 2001.